A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

Small Cell ◽

Oncology Group ◽

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/85.5.388 ◽

1993 ◽

Vol 85 (5) ◽

pp. 388-394 ◽

Cited By ~ 233

Author(s):

A. Y. Chang ◽

K. Kim ◽

J. Glick ◽

T. Anderson ◽

D. Karp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iv ◽

Small Cell ◽

Oncology Group ◽

Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study

Lung Cancer ◽

10.1016/s0169-5002(01)00429-9 ◽

2002 ◽

Vol 35 (3) ◽

pp. 293-297 ◽

Cited By ~ 15

Author(s):

Nasser Hanna ◽

Rafat Ansari ◽

William Fisher ◽

Jianzhao Shen ◽

Sin-Ho Jung ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

Medical and Pediatric Oncology ◽

10.1002/mpo.2950170306 ◽

1989 ◽

Vol 17 (3) ◽

pp. 197-201 ◽

Cited By ~ 10

Author(s):

David S. Ettinger ◽

Dianne M. Finkelstein ◽

Ross C. Donehower ◽

Alex Y. C. Chang ◽

Michael Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90355-p ◽

1990 ◽

Vol 6 (1-2) ◽

pp. 58-59

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial

Lung Cancer ◽

10.1016/s0169-5002(97)89649-3 ◽

1997 ◽

Vol 18 ◽

pp. 70

Author(s):

A.B. Sandler ◽

R. Ansari ◽

W. Fisher ◽

R. Gonin ◽

R. Levy ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70153-2 ◽

2006 ◽

Vol 2006 ◽

pp. 218-219

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Radiation Therapy Oncology Group ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.006 ◽

2021 ◽

Author(s):

Akira Hamada ◽

Junichi Soh ◽

Akito Hata ◽

Kiyoshi Nakamatsu ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

Adjuvant Immunotherapy

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

Cancer ◽

10.1002/1097-0142(19940815)74:4<1243::aid-cncr2820740411>3.0.co;2-d ◽

1994 ◽

Vol 74 (4) ◽

pp. 1243-1252 ◽

Cited By ~ 45

Author(s):

Margaret Deutsch ◽

Jeffrey Crawford ◽

Kenneth Leopold ◽

Walter Wolfe ◽

William Foster ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1097/01243894-200609000-00012 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678 ◽

Cited By ~ 3

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

Lung Cancer ◽

10.1016/s0169-5002(05)81267-x ◽

2005 ◽

Vol 49 ◽

pp. S322 ◽

Cited By ~ 1

Author(s):

T. Kashii ◽

H. Saito ◽

S. Negoro ◽

Y. Takada ◽

Y. Ichinose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Group Trial